nafamostat has been researched along with diminazene in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Gründer, S; Wiemuth, D | 1 |
| Alix, M; Boehm, T; Borth, N; Gludovacz, E; Jilma, B; Petroczi, K; Salminen, TA; Vakal, S | 1 |
| Barygin, OI; Tikhonov, DB; Zhigulin, AS | 1 |
3 other study(ies) available for nafamostat and diminazene
| Article | Year |
|---|---|
The pharmacological profile of brain liver intestine Na+ channel: inhibition by diarylamidines and activation by fenamates.
Topics: Amiloride; Animals; Benzamidines; Brain; Diminazene; Dose-Response Relationship, Drug; Fenamates; Guanidines; Intestinal Mucosa; Liver; Rats; Sodium Channel Blockers; Sodium Channels; Xenopus laevis | 2011 |
Nafamostat is a Potent Human Diamine Oxidase Inhibitor Possibly Augmenting Hypersensitivity Reactions during Nafamostat Administration.
Topics: Amine Oxidase (Copper-Containing); Anaphylaxis; Benzamidines; Diminazene; Edetic Acid; Guanidines; Histamine; Humans | 2022 |
Mechanisms of acid-sensing ion channels inhibition by nafamostat, sepimostat and diminazene.
Topics: Acid Sensing Ion Channels; Animals; Diminazene; Gabexate; Guanidines; Hydrogen-Ion Concentration; Rats | 2023 |